Results 21 to 30 of about 112,020 (111)
Barriers to effective treatment of vaginal atrophy with local estrogen therapy
Suzanne ReiterMid-County Health Center, Largo, FL, USAAbstract: Vaginal atrophy is a common condition among postmenopausal women, among whom many exhibit both vulvovaginal symptoms (eg, dryness, irritation, itching, and pain with intercourse) and urinary
Reiter S
doaj +1 more source
Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up
Objective: The aim of this study was to evaluate the safety and efficacy of fractional CO2 laser for treatment of vulvovaginal atrophy. Materials and methods: In this clinical trial study, we evaluated the laser effect on vulvovaginal atrophy in 47 women
Zinat Ghanbari +6 more
doaj +1 more source
Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India. [PDF]
BACKGROUND: Vulvovaginal candidiasis is characterized by curd-like vaginal discharge and itching, and is associated with considerable health and economic costs.
Madhivanan, Purnima +9 more
core +1 more source
Hypoestrogenism associated with menopause has a strong negative effect on the condition of the vagina and urinary tract, and often leads to the development of genitourinary menopausal syndrome, significantly disrupting the quality of life of women ...
Liana Z. Ziganshina +3 more
doaj +1 more source
Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
Menopause is a physiological and progressive phenomenon secondary to decreased ovarian follicular reserve that significantly affects the genital tract. Although postmenopausal vulvovaginal atrophy primarily affects postmenopausal women, it is also seen ...
Ana Paula Ferreira Costa +7 more
doaj +1 more source
Women’s Sexual Dysfunctions Following Stem Cell Transplant and the Impact on Couple Relationship
Stem cell transplant proved its efficacy in increasing the survival rate among young patients diagnosed with hematological malignancies. A transplant conditioning regimen is particularly destructive on the genital system, often determining premature ...
Mihaela Plotogea +11 more
doaj +1 more source
Laser therapy in managing vulvovaginal atrophy after breast cancer treatment. [PDF]
Aim of the study: to select and analyse publications regarding vaginal laser therapy in managing vulvovaginal atrophy after breast cancer treatment. Objectives: 1) To assess the efficacy of vaginal laser in managing vulvovaginal atrophy for patients ...
Jugulytė, Nida,
core
Gray matter atrophy rate as a marker of disease progression in AD [PDF]
Global gray matter (GM) atrophy rates were quantified from magnetic resonance imaging (MRI) over 6- and 12-month intervals in 37 patients with Alzheimer's disease (AD) and 19 controls using: (1) nonlinear registration and integration of Jacobian values ...
Miller, David H. +29 more
core +1 more source
Background. Vulvovaginal atrophy is a chronic, progressive condition associated with estrogen deficiency. While involutional changes are well-documented, the relationship between the vaginal microbiota and the local immune response in vulvovaginal ...
M. I. Biryukova +2 more
doaj +1 more source
Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy
Vulvovaginal atrophy is frequent, can be bothersome and can impair quality of life in postmenopausal women. The main objective of this prospective, randomized study was to compare the acceptability of low-dose vaginal 17β-estradiol (estradiol) tablets ...
S. Palacios (810500) +2 more
core +1 more source

